SlideShare a Scribd company logo
1 of 16
Women’s Perception of Cardiovascular
 Disease Risk Varies by Hyperlipidemia
 History: Data from the Making Effective
   Nutritional (MENU) Choices Study
  Andrea E. Cassidy-Bushrow, PhD, MPH, Gwen Alexander, PhD,
Frank R. Lawrence, PhD, Henry Ford Hospital; Jennifer B. McClure,
 PhD, Group Health Research Institute; Debra P. Ritzwoller, PhD,
      Kaiser Permanente Colorado; Sharon J. Rolnick, PhD,
  HealthPartners Research Foundation; Dennis D. Tolsma, MPH,
 Kaiser Permanente Georgia; Christine Cole Johnson, PhD, MPH,
                     Henry Ford Hospital.

         17th Annual HMO Research Network Conference
Background
Cardiovascular disease (CVD) traditionally
considered an “older man’s disease”
American Heart Association Go Red For
Women campaign launched in 2004 to
increase women’s awareness of CVD
Increasing numbers of women now aware
that CVD is #1 cause of death of women
Background
• Over half of CVD attributable to hyperlipidemia
• Recognition of hyperlipidemia as CVD risk
  factor lacking
• Women with hyperlipidemia worry more about
  CVD than those without
• However, >1/3 of women with hyperlipidemia do
  not worry about CVD
• Hyperlipidemia diagnosis and treatment
  particularly challenging in women
   • Variable screening rates in young women
   • Contraindicated treatments (statins) for women
     of child-bearing potential
Purpose

To examine if the perceived risk of
CVD varies by hyperlipidemia status
   in women, overall, and by age
MENU Choices Study
• Web-based, 5-site randomized intervention trial
   • Encouraged increased intake of fruit and vegetables
   • “Healthy” population target group
   • Optimized use of technology (email and internet)
   • “Real world” application
  Longitudinal study (baseline, 3, 6, 12 month measures)
  Three intervention arms:
   • Untailored website
   • Tailored website
   • Tailored website + Behavioral counseling via email
MENU Study Sample
• Eligibility:
  • Age 21 – 65 years
  • No contraindication to increasing fruit and
    vegetable intake
  • Access to internet for personal use
  • Working email account checked ≥1/week
Recruitment methods
• Recruitment spanned 09/2005 – 03/2006
• African Americans over-sampled at 2 sites and Hispanics
  over-sampled at 1 site
• Single mailing of invitation letter included:
   • Business-style envelope with Health Plan logo, metered mail, sent
     locally
   • Web address and unique sign-on code
   • $2 bill to gain “attention”
  $20 incentive for completing each follow-up survey
  Online enrollment including eligibility, consent, email
  verification, baseline and follow-up surveys
  Letter and automated email prompts
Measures
• Hyperlipidemia history defined as:
  • Self-reported diagnosis and/or
  • Reported use of anti-hyperlipidemics
 Perceived personal risk of CVD measured
 on ordinal scale (1) not at all to (5)
 extremely likely
Analytic sample
• Restricted to women (N=1,729)
• Exclusions
  • Pre-existing CVD
  • Missing data
 Final analytical sample 1,693 women
Statistical Analysis
• Association of hyperlipidemia with
  perceived risk of CVD estimated using
  Bayesian proportional odds models
• To account for potential residual
  confounding, a propensity-score approach
  utilized as a sensitivity analysis (variables
  used: age, diabetes, body mass index
  (BMI), marital status, hypertension, family
  history of CVD)
Results
                                Hyperlipidemia        No Hyperlipidemia
N                                 382 (22.6%)            1311 (77.4%)
Age (years)                         51.0±8.6               43.0±10.6
<High-school education            43 (11.2%)               102 (7.8%)
Married/living with partner       253 (66.2%)             903 (68.9%)
African-American                  112 (29.7%)             286 (22.2%)
BMI (kg/m2)                         31.0±7.0                28.0±6.8
Child <18 in home                 106 (27.7%)             636 (48.5%)
Currently smoke                   45 (11.8%)               129 (9.8%)
Physically active                 198 (51.8%)             788 (60.1%)
Family history CVD                157 (41.1%)             332 (25.3%)

                    Data are N (%) or mean±standard deviation
Results
                      40
                      35
     Proportion (%)

                      30
                      25
                      20
                      15
                      10
                       5
                       0
                           Not at all     Little   Somewhat      Lot         Extremely
                                             Percieved risk of CVD

                                        Hyperlipidemia   No Hyperlipidemia

After adjusting for age, BMI and race, women with
hyperlipidemia had a mean increase in perceived CVD risk
of 1.2 (95% CI posterior mean = 0.6, 1.7; P=0.001) compared
to women without hyperlipidemia
Results
Results similar, although somewhat
attenuated in propensity-score matched
group (mean increase of 0.61; 95% CI
posterior mean = 0.23, 1.0; P=0.001)
Conclusions
• Women with hyperlipidemia perceive a
  greater personal risk of CVD than women
  without hyperlipidemia
• However, nearly 40% of women with
  hyperlipidemia consider themselves at no to
  little risk of CVD – an important and
  modifiable knowledge gap
Future Directions
As a result of the Go Red For Women campaign,
many studies investigated CVD awareness/
knowledge only in women
Direct comparison to the experiences of men still
needed/warranted
MENU study conducted in mid 2000’s, at time
Go Red For Women campaign was starting
A more contemporaneous study may reveal a
dwindling gap between risk factor presence and
perceived risk of disease
Collaborating Sites
  Group Health Cooperative:    Jennifer McClure, PhD
   Seattle                     Julie Richards, Paula Sandler
                               Roy Pardee
  HealthPartners:              Cheri Rolnick, PhD
   Minneapolis                 Mary Kelley, MPH, Ann Hanson
  HFHS/HAP:                    Christine Cole Johnson, PhD, Gwen Alexander, PhD
   Detroit                     George Divine, PhD, Nancy Oje-Tebbe
                               Sarah Claud, MPH, Heidi Kromrei,MA
                               Rick Krajenta, Noel Maddy
  KP Colorado:                 Deb Ritzwoller, PhD, Anna Sukhanova
    Denver                     Melanie Stopponi, MPA, Nikki Carroll
  KP Georgia:                  Dennis Tolsma, MPH
    Atlalnta                   Jody Calvi, MPH

  U Michigan Center for
  Health Communications*:     Vic Strecher, PhD
                               Ed Saunders, Carola Carlier
                              Janine Konkel, Mike Nowak


  Consultants:                Mick Couper (UM Inst Soc Research)
                              Marci Campbell, PhD, UNC
                              Ken Resnicow, PhD, U Michigan
                              Jerianne Heimendinger, PhD, RD
                              Fran Thompson, PhD, RD
                              Tom Hurley, PhD

 *Plus project team members, pilot testers and UM HMRL staff

More Related Content

What's hot

An approach to mulitmorbidity in frail older adults
An approach to mulitmorbidity in frail older adultsAn approach to mulitmorbidity in frail older adults
An approach to mulitmorbidity in frail older adultsCamilla Wong
 
Prevention in Her Hands: Findings from a PrEP Demonstration Study of Cisgende...
Prevention in Her Hands: Findings from a PrEP Demonstration Study of Cisgende...Prevention in Her Hands: Findings from a PrEP Demonstration Study of Cisgende...
Prevention in Her Hands: Findings from a PrEP Demonstration Study of Cisgende...UC San Diego AntiViral Research Center
 
Geriatric Oncology
Geriatric OncologyGeriatric Oncology
Geriatric OncologyCamilla Wong
 
Alzheimer
AlzheimerAlzheimer
AlzheimerHarold
 
Statin Use Cancer Related Mortality M Wilmath Nov2012 Whh Adult Med
Statin Use Cancer Related Mortality M Wilmath Nov2012 Whh Adult MedStatin Use Cancer Related Mortality M Wilmath Nov2012 Whh Adult Med
Statin Use Cancer Related Mortality M Wilmath Nov2012 Whh Adult MedMario Wilmath
 
7. hcv treatment for pwid final
7. hcv treatment for pwid final7. hcv treatment for pwid final
7. hcv treatment for pwid finalantoine piaton
 
Geriatric Trauma Collaborative Care
Geriatric Trauma Collaborative CareGeriatric Trauma Collaborative Care
Geriatric Trauma Collaborative CareCamilla Wong
 
Disparities in Antihypertensive Medication Adherence ADAMS
Disparities in Antihypertensive Medication Adherence ADAMSDisparities in Antihypertensive Medication Adherence ADAMS
Disparities in Antihypertensive Medication Adherence ADAMSHMO Research Network
 
MON 2011 - Slide 27 - S. Faithfull - Spotlight session - Survivorship
MON 2011 - Slide 27 - S. Faithfull - Spotlight session - SurvivorshipMON 2011 - Slide 27 - S. Faithfull - Spotlight session - Survivorship
MON 2011 - Slide 27 - S. Faithfull - Spotlight session - SurvivorshipEuropean School of Oncology
 
Age Bias in Cancer Care
Age Bias in Cancer CareAge Bias in Cancer Care
Age Bias in Cancer Carebkling
 
Susan Mitchell-Care of the Patient with Advanced Dementia: What Physicians Ne...
Susan Mitchell-Care of the Patient with Advanced Dementia: What Physicians Ne...Susan Mitchell-Care of the Patient with Advanced Dementia: What Physicians Ne...
Susan Mitchell-Care of the Patient with Advanced Dementia: What Physicians Ne...jewishhome
 
Pattern of cancer in adolescent and young adults
Pattern of cancer in adolescent and young adultsPattern of cancer in adolescent and young adults
Pattern of cancer in adolescent and young adultsdrkalyanir
 
Factors underlying adherence to lymphoedema risk reduction
Factors underlying adherence to lymphoedema risk reductionFactors underlying adherence to lymphoedema risk reduction
Factors underlying adherence to lymphoedema risk reductionCancer Institute NSW
 
HIv risks and vulnerabilities among Gay, Bisexuals and Others MSM, Stefan Baral
HIv risks and vulnerabilities among Gay, Bisexuals and Others MSM, Stefan BaralHIv risks and vulnerabilities among Gay, Bisexuals and Others MSM, Stefan Baral
HIv risks and vulnerabilities among Gay, Bisexuals and Others MSM, Stefan BaralMSMGF
 
Carle Palliative Care Journal Club 1/15/2020
Carle Palliative Care Journal Club 1/15/2020Carle Palliative Care Journal Club 1/15/2020
Carle Palliative Care Journal Club 1/15/2020Mike Aref
 
Importance of Education on Breast Cancer-related Lymphedema
Importance of Education on Breast Cancer-related LymphedemaImportance of Education on Breast Cancer-related Lymphedema
Importance of Education on Breast Cancer-related Lymphedemailfconference
 
Integrated Cancer Prevention
Integrated Cancer Prevention Integrated Cancer Prevention
Integrated Cancer Prevention Lisa Nelson
 
Third Annual Early Age Onset Colorectal Cancer Symposium - Optimizing Outcome...
Third Annual Early Age Onset Colorectal Cancer Symposium - Optimizing Outcome...Third Annual Early Age Onset Colorectal Cancer Symposium - Optimizing Outcome...
Third Annual Early Age Onset Colorectal Cancer Symposium - Optimizing Outcome...Colon Cancer Challenge Foundation
 
End stage dementia and palliative care
End stage dementia and palliative care End stage dementia and palliative care
End stage dementia and palliative care Toluwalase A. Ajayi
 

What's hot (20)

5th Annual Early Age Onset Colorectal Cancer - Session VI
5th Annual Early Age Onset Colorectal Cancer - Session VI5th Annual Early Age Onset Colorectal Cancer - Session VI
5th Annual Early Age Onset Colorectal Cancer - Session VI
 
An approach to mulitmorbidity in frail older adults
An approach to mulitmorbidity in frail older adultsAn approach to mulitmorbidity in frail older adults
An approach to mulitmorbidity in frail older adults
 
Prevention in Her Hands: Findings from a PrEP Demonstration Study of Cisgende...
Prevention in Her Hands: Findings from a PrEP Demonstration Study of Cisgende...Prevention in Her Hands: Findings from a PrEP Demonstration Study of Cisgende...
Prevention in Her Hands: Findings from a PrEP Demonstration Study of Cisgende...
 
Geriatric Oncology
Geriatric OncologyGeriatric Oncology
Geriatric Oncology
 
Alzheimer
AlzheimerAlzheimer
Alzheimer
 
Statin Use Cancer Related Mortality M Wilmath Nov2012 Whh Adult Med
Statin Use Cancer Related Mortality M Wilmath Nov2012 Whh Adult MedStatin Use Cancer Related Mortality M Wilmath Nov2012 Whh Adult Med
Statin Use Cancer Related Mortality M Wilmath Nov2012 Whh Adult Med
 
7. hcv treatment for pwid final
7. hcv treatment for pwid final7. hcv treatment for pwid final
7. hcv treatment for pwid final
 
Geriatric Trauma Collaborative Care
Geriatric Trauma Collaborative CareGeriatric Trauma Collaborative Care
Geriatric Trauma Collaborative Care
 
Disparities in Antihypertensive Medication Adherence ADAMS
Disparities in Antihypertensive Medication Adherence ADAMSDisparities in Antihypertensive Medication Adherence ADAMS
Disparities in Antihypertensive Medication Adherence ADAMS
 
MON 2011 - Slide 27 - S. Faithfull - Spotlight session - Survivorship
MON 2011 - Slide 27 - S. Faithfull - Spotlight session - SurvivorshipMON 2011 - Slide 27 - S. Faithfull - Spotlight session - Survivorship
MON 2011 - Slide 27 - S. Faithfull - Spotlight session - Survivorship
 
Age Bias in Cancer Care
Age Bias in Cancer CareAge Bias in Cancer Care
Age Bias in Cancer Care
 
Susan Mitchell-Care of the Patient with Advanced Dementia: What Physicians Ne...
Susan Mitchell-Care of the Patient with Advanced Dementia: What Physicians Ne...Susan Mitchell-Care of the Patient with Advanced Dementia: What Physicians Ne...
Susan Mitchell-Care of the Patient with Advanced Dementia: What Physicians Ne...
 
Pattern of cancer in adolescent and young adults
Pattern of cancer in adolescent and young adultsPattern of cancer in adolescent and young adults
Pattern of cancer in adolescent and young adults
 
Factors underlying adherence to lymphoedema risk reduction
Factors underlying adherence to lymphoedema risk reductionFactors underlying adherence to lymphoedema risk reduction
Factors underlying adherence to lymphoedema risk reduction
 
HIv risks and vulnerabilities among Gay, Bisexuals and Others MSM, Stefan Baral
HIv risks and vulnerabilities among Gay, Bisexuals and Others MSM, Stefan BaralHIv risks and vulnerabilities among Gay, Bisexuals and Others MSM, Stefan Baral
HIv risks and vulnerabilities among Gay, Bisexuals and Others MSM, Stefan Baral
 
Carle Palliative Care Journal Club 1/15/2020
Carle Palliative Care Journal Club 1/15/2020Carle Palliative Care Journal Club 1/15/2020
Carle Palliative Care Journal Club 1/15/2020
 
Importance of Education on Breast Cancer-related Lymphedema
Importance of Education on Breast Cancer-related LymphedemaImportance of Education on Breast Cancer-related Lymphedema
Importance of Education on Breast Cancer-related Lymphedema
 
Integrated Cancer Prevention
Integrated Cancer Prevention Integrated Cancer Prevention
Integrated Cancer Prevention
 
Third Annual Early Age Onset Colorectal Cancer Symposium - Optimizing Outcome...
Third Annual Early Age Onset Colorectal Cancer Symposium - Optimizing Outcome...Third Annual Early Age Onset Colorectal Cancer Symposium - Optimizing Outcome...
Third Annual Early Age Onset Colorectal Cancer Symposium - Optimizing Outcome...
 
End stage dementia and palliative care
End stage dementia and palliative care End stage dementia and palliative care
End stage dementia and palliative care
 

Similar to Women’s Perception of Cardiovascular Disease Risk Varies by Hyperlipidemia History CASSIDY

"How Scientific Wellness will Drive The Future of Health" - Nathan Price (Pro...
"How Scientific Wellness will Drive The Future of Health" - Nathan Price (Pro..."How Scientific Wellness will Drive The Future of Health" - Nathan Price (Pro...
"How Scientific Wellness will Drive The Future of Health" - Nathan Price (Pro...Hyper Wellbeing
 
Cervcal cancer prevention in sa
Cervcal cancer prevention in saCervcal cancer prevention in sa
Cervcal cancer prevention in saTariq Mohammed
 
Secondary Cancers, Health Behaviour and Cancer Screening Adherence in survivo...
Secondary Cancers, Health Behaviour and Cancer Screening Adherence in survivo...Secondary Cancers, Health Behaviour and Cancer Screening Adherence in survivo...
Secondary Cancers, Health Behaviour and Cancer Screening Adherence in survivo...Cancer Institute NSW
 
Colorectal Cancer Risk & Risk Reduction: Jan 2017 #CRCWebinar
Colorectal Cancer Risk & Risk Reduction: Jan 2017 #CRCWebinarColorectal Cancer Risk & Risk Reduction: Jan 2017 #CRCWebinar
Colorectal Cancer Risk & Risk Reduction: Jan 2017 #CRCWebinarFight Colorectal Cancer
 
Why are Breast Cancers More Aggressive in Black Women?
Why are Breast Cancers More Aggressive in Black Women?Why are Breast Cancers More Aggressive in Black Women?
Why are Breast Cancers More Aggressive in Black Women?bkling
 
Brian Sick, M.D.
Brian Sick, M.D.Brian Sick, M.D.
Brian Sick, M.D.smsherman
 
The power of personal choices
The power of personal choicesThe power of personal choices
The power of personal choicesEsserHealth
 
What is Cancer Equity?
What is Cancer Equity?What is Cancer Equity?
What is Cancer Equity?EngenuitySC
 
Sanjeev Arora, MD, Director, Project Echo
Sanjeev Arora, MD, Director, Project EchoSanjeev Arora, MD, Director, Project Echo
Sanjeev Arora, MD, Director, Project EchoInvestnet
 
Family Genetics - Having the Conversation with Family
Family Genetics - Having the Conversation with FamilyFamily Genetics - Having the Conversation with Family
Family Genetics - Having the Conversation with FamilyFight Colorectal Cancer
 
Improved Outcomes from Diabetes Outreach Programs in Rural and Remote Aborigi...
Improved Outcomes from Diabetes Outreach Programs in Rural and Remote Aborigi...Improved Outcomes from Diabetes Outreach Programs in Rural and Remote Aborigi...
Improved Outcomes from Diabetes Outreach Programs in Rural and Remote Aborigi...Kelli Buckreus
 
Dollars and sense 2012
Dollars and sense 2012Dollars and sense 2012
Dollars and sense 2012EsserHealth
 
Recent advances in the diagnosis and treatment of thyroid cancer
Recent advances in the diagnosis and treatment of thyroid cancerRecent advances in the diagnosis and treatment of thyroid cancer
Recent advances in the diagnosis and treatment of thyroid cancerHealthXn
 
Slides on Diabetes in the South Focus on Prevention.2018
Slides on Diabetes in the South Focus on Prevention.2018Slides on Diabetes in the South Focus on Prevention.2018
Slides on Diabetes in the South Focus on Prevention.2018hivlifeinfo
 

Similar to Women’s Perception of Cardiovascular Disease Risk Varies by Hyperlipidemia History CASSIDY (20)

"How Scientific Wellness will Drive The Future of Health" - Nathan Price (Pro...
"How Scientific Wellness will Drive The Future of Health" - Nathan Price (Pro..."How Scientific Wellness will Drive The Future of Health" - Nathan Price (Pro...
"How Scientific Wellness will Drive The Future of Health" - Nathan Price (Pro...
 
Cervcal cancer prevention in sa
Cervcal cancer prevention in saCervcal cancer prevention in sa
Cervcal cancer prevention in sa
 
Secondary Cancers, Health Behaviour and Cancer Screening Adherence in survivo...
Secondary Cancers, Health Behaviour and Cancer Screening Adherence in survivo...Secondary Cancers, Health Behaviour and Cancer Screening Adherence in survivo...
Secondary Cancers, Health Behaviour and Cancer Screening Adherence in survivo...
 
dod_clanton.ppt
dod_clanton.pptdod_clanton.ppt
dod_clanton.ppt
 
cancer
cancercancer
cancer
 
dod_clanton.ppt
dod_clanton.pptdod_clanton.ppt
dod_clanton.ppt
 
dod_clanton.ppt
dod_clanton.pptdod_clanton.ppt
dod_clanton.ppt
 
Colorectal Cancer Risk & Risk Reduction: Jan 2017 #CRCWebinar
Colorectal Cancer Risk & Risk Reduction: Jan 2017 #CRCWebinarColorectal Cancer Risk & Risk Reduction: Jan 2017 #CRCWebinar
Colorectal Cancer Risk & Risk Reduction: Jan 2017 #CRCWebinar
 
Why are Breast Cancers More Aggressive in Black Women?
Why are Breast Cancers More Aggressive in Black Women?Why are Breast Cancers More Aggressive in Black Women?
Why are Breast Cancers More Aggressive in Black Women?
 
Brian Sick, M.D.
Brian Sick, M.D.Brian Sick, M.D.
Brian Sick, M.D.
 
The power of personal choices
The power of personal choicesThe power of personal choices
The power of personal choices
 
What is Cancer Equity?
What is Cancer Equity?What is Cancer Equity?
What is Cancer Equity?
 
Sanjeev Arora, MD, Director, Project Echo
Sanjeev Arora, MD, Director, Project EchoSanjeev Arora, MD, Director, Project Echo
Sanjeev Arora, MD, Director, Project Echo
 
Integrative Oncology
Integrative OncologyIntegrative Oncology
Integrative Oncology
 
Family Genetics - Having the Conversation with Family
Family Genetics - Having the Conversation with FamilyFamily Genetics - Having the Conversation with Family
Family Genetics - Having the Conversation with Family
 
Improved Outcomes from Diabetes Outreach Programs in Rural and Remote Aborigi...
Improved Outcomes from Diabetes Outreach Programs in Rural and Remote Aborigi...Improved Outcomes from Diabetes Outreach Programs in Rural and Remote Aborigi...
Improved Outcomes from Diabetes Outreach Programs in Rural and Remote Aborigi...
 
Dollars and sense 2012
Dollars and sense 2012Dollars and sense 2012
Dollars and sense 2012
 
Recent advances in the diagnosis and treatment of thyroid cancer
Recent advances in the diagnosis and treatment of thyroid cancerRecent advances in the diagnosis and treatment of thyroid cancer
Recent advances in the diagnosis and treatment of thyroid cancer
 
Slides on Diabetes in the South Focus on Prevention.2018
Slides on Diabetes in the South Focus on Prevention.2018Slides on Diabetes in the South Focus on Prevention.2018
Slides on Diabetes in the South Focus on Prevention.2018
 
Early Age Onset (EAO) Working Meeting
Early Age Onset (EAO) Working MeetingEarly Age Onset (EAO) Working Meeting
Early Age Onset (EAO) Working Meeting
 

More from HMO Research Network

New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...
New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...
New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...HMO Research Network
 
Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...
Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...
Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...HMO Research Network
 
Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...
Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...
Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...HMO Research Network
 
A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...
A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...
A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...HMO Research Network
 
A Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGER
A Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGERA Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGER
A Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGERHMO Research Network
 
The Use of Administrative Data and Natural Language Processing to Estimate th...
The Use of Administrative Data and Natural Language Processing to Estimate th...The Use of Administrative Data and Natural Language Processing to Estimate th...
The Use of Administrative Data and Natural Language Processing to Estimate th...HMO Research Network
 
Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...
Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...
Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...HMO Research Network
 
Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...
Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...
Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...HMO Research Network
 
CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...
CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...
CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...HMO Research Network
 
An Application of Doubly Robust Estimation JOHNSON
An Application of Doubly Robust Estimation JOHNSONAn Application of Doubly Robust Estimation JOHNSON
An Application of Doubly Robust Estimation JOHNSONHMO Research Network
 
Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...
Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...
Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...HMO Research Network
 
Expanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOK
Expanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOKExpanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOK
Expanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOKHMO Research Network
 
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...Drug Characteristics Associated with Medication Adherence Across Eight Diseas...
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...HMO Research Network
 
Feasibility of Implementing Screening Brief Intervention and Referral to Trea...
Feasibility of Implementing Screening Brief Intervention and Referral to Trea...Feasibility of Implementing Screening Brief Intervention and Referral to Trea...
Feasibility of Implementing Screening Brief Intervention and Referral to Trea...HMO Research Network
 
eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...
eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...
eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...HMO Research Network
 
A Telephone Based Diabetes Prevention Program and Social Support for Weight L...
A Telephone Based Diabetes Prevention Program and Social Support for Weight L...A Telephone Based Diabetes Prevention Program and Social Support for Weight L...
A Telephone Based Diabetes Prevention Program and Social Support for Weight L...HMO Research Network
 
Technological Resources & Personnel Costs Required to Implement an Automated ...
Technological Resources & Personnel Costs Required to Implement an Automated ...Technological Resources & Personnel Costs Required to Implement an Automated ...
Technological Resources & Personnel Costs Required to Implement an Automated ...HMO Research Network
 
Online Patient Access to their Medical Record and Health Providers is Associa...
Online Patient Access to their Medical Record and Health Providers is Associa...Online Patient Access to their Medical Record and Health Providers is Associa...
Online Patient Access to their Medical Record and Health Providers is Associa...HMO Research Network
 
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALE
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALEDocumentations of Advanced Heath Care Directives Where Are They TAI_SEALE
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALEHMO Research Network
 

More from HMO Research Network (20)

New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...
New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...
New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...
 
From Populations to Patients
From Populations to PatientsFrom Populations to Patients
From Populations to Patients
 
Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...
Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...
Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...
 
Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...
Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...
Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...
 
A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...
A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...
A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...
 
A Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGER
A Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGERA Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGER
A Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGER
 
The Use of Administrative Data and Natural Language Processing to Estimate th...
The Use of Administrative Data and Natural Language Processing to Estimate th...The Use of Administrative Data and Natural Language Processing to Estimate th...
The Use of Administrative Data and Natural Language Processing to Estimate th...
 
Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...
Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...
Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...
 
Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...
Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...
Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...
 
CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...
CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...
CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...
 
An Application of Doubly Robust Estimation JOHNSON
An Application of Doubly Robust Estimation JOHNSONAn Application of Doubly Robust Estimation JOHNSON
An Application of Doubly Robust Estimation JOHNSON
 
Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...
Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...
Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...
 
Expanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOK
Expanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOKExpanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOK
Expanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOK
 
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...Drug Characteristics Associated with Medication Adherence Across Eight Diseas...
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...
 
Feasibility of Implementing Screening Brief Intervention and Referral to Trea...
Feasibility of Implementing Screening Brief Intervention and Referral to Trea...Feasibility of Implementing Screening Brief Intervention and Referral to Trea...
Feasibility of Implementing Screening Brief Intervention and Referral to Trea...
 
eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...
eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...
eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...
 
A Telephone Based Diabetes Prevention Program and Social Support for Weight L...
A Telephone Based Diabetes Prevention Program and Social Support for Weight L...A Telephone Based Diabetes Prevention Program and Social Support for Weight L...
A Telephone Based Diabetes Prevention Program and Social Support for Weight L...
 
Technological Resources & Personnel Costs Required to Implement an Automated ...
Technological Resources & Personnel Costs Required to Implement an Automated ...Technological Resources & Personnel Costs Required to Implement an Automated ...
Technological Resources & Personnel Costs Required to Implement an Automated ...
 
Online Patient Access to their Medical Record and Health Providers is Associa...
Online Patient Access to their Medical Record and Health Providers is Associa...Online Patient Access to their Medical Record and Health Providers is Associa...
Online Patient Access to their Medical Record and Health Providers is Associa...
 
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALE
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALEDocumentations of Advanced Heath Care Directives Where Are They TAI_SEALE
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALE
 

Women’s Perception of Cardiovascular Disease Risk Varies by Hyperlipidemia History CASSIDY

  • 1. Women’s Perception of Cardiovascular Disease Risk Varies by Hyperlipidemia History: Data from the Making Effective Nutritional (MENU) Choices Study Andrea E. Cassidy-Bushrow, PhD, MPH, Gwen Alexander, PhD, Frank R. Lawrence, PhD, Henry Ford Hospital; Jennifer B. McClure, PhD, Group Health Research Institute; Debra P. Ritzwoller, PhD, Kaiser Permanente Colorado; Sharon J. Rolnick, PhD, HealthPartners Research Foundation; Dennis D. Tolsma, MPH, Kaiser Permanente Georgia; Christine Cole Johnson, PhD, MPH, Henry Ford Hospital. 17th Annual HMO Research Network Conference
  • 2. Background Cardiovascular disease (CVD) traditionally considered an “older man’s disease” American Heart Association Go Red For Women campaign launched in 2004 to increase women’s awareness of CVD Increasing numbers of women now aware that CVD is #1 cause of death of women
  • 3. Background • Over half of CVD attributable to hyperlipidemia • Recognition of hyperlipidemia as CVD risk factor lacking • Women with hyperlipidemia worry more about CVD than those without • However, >1/3 of women with hyperlipidemia do not worry about CVD • Hyperlipidemia diagnosis and treatment particularly challenging in women • Variable screening rates in young women • Contraindicated treatments (statins) for women of child-bearing potential
  • 4. Purpose To examine if the perceived risk of CVD varies by hyperlipidemia status in women, overall, and by age
  • 5. MENU Choices Study • Web-based, 5-site randomized intervention trial • Encouraged increased intake of fruit and vegetables • “Healthy” population target group • Optimized use of technology (email and internet) • “Real world” application Longitudinal study (baseline, 3, 6, 12 month measures) Three intervention arms: • Untailored website • Tailored website • Tailored website + Behavioral counseling via email
  • 6. MENU Study Sample • Eligibility: • Age 21 – 65 years • No contraindication to increasing fruit and vegetable intake • Access to internet for personal use • Working email account checked ≥1/week
  • 7. Recruitment methods • Recruitment spanned 09/2005 – 03/2006 • African Americans over-sampled at 2 sites and Hispanics over-sampled at 1 site • Single mailing of invitation letter included: • Business-style envelope with Health Plan logo, metered mail, sent locally • Web address and unique sign-on code • $2 bill to gain “attention” $20 incentive for completing each follow-up survey Online enrollment including eligibility, consent, email verification, baseline and follow-up surveys Letter and automated email prompts
  • 8. Measures • Hyperlipidemia history defined as: • Self-reported diagnosis and/or • Reported use of anti-hyperlipidemics Perceived personal risk of CVD measured on ordinal scale (1) not at all to (5) extremely likely
  • 9. Analytic sample • Restricted to women (N=1,729) • Exclusions • Pre-existing CVD • Missing data Final analytical sample 1,693 women
  • 10. Statistical Analysis • Association of hyperlipidemia with perceived risk of CVD estimated using Bayesian proportional odds models • To account for potential residual confounding, a propensity-score approach utilized as a sensitivity analysis (variables used: age, diabetes, body mass index (BMI), marital status, hypertension, family history of CVD)
  • 11. Results Hyperlipidemia No Hyperlipidemia N 382 (22.6%) 1311 (77.4%) Age (years) 51.0±8.6 43.0±10.6 <High-school education 43 (11.2%) 102 (7.8%) Married/living with partner 253 (66.2%) 903 (68.9%) African-American 112 (29.7%) 286 (22.2%) BMI (kg/m2) 31.0±7.0 28.0±6.8 Child <18 in home 106 (27.7%) 636 (48.5%) Currently smoke 45 (11.8%) 129 (9.8%) Physically active 198 (51.8%) 788 (60.1%) Family history CVD 157 (41.1%) 332 (25.3%) Data are N (%) or mean±standard deviation
  • 12. Results 40 35 Proportion (%) 30 25 20 15 10 5 0 Not at all Little Somewhat Lot Extremely Percieved risk of CVD Hyperlipidemia No Hyperlipidemia After adjusting for age, BMI and race, women with hyperlipidemia had a mean increase in perceived CVD risk of 1.2 (95% CI posterior mean = 0.6, 1.7; P=0.001) compared to women without hyperlipidemia
  • 13. Results Results similar, although somewhat attenuated in propensity-score matched group (mean increase of 0.61; 95% CI posterior mean = 0.23, 1.0; P=0.001)
  • 14. Conclusions • Women with hyperlipidemia perceive a greater personal risk of CVD than women without hyperlipidemia • However, nearly 40% of women with hyperlipidemia consider themselves at no to little risk of CVD – an important and modifiable knowledge gap
  • 15. Future Directions As a result of the Go Red For Women campaign, many studies investigated CVD awareness/ knowledge only in women Direct comparison to the experiences of men still needed/warranted MENU study conducted in mid 2000’s, at time Go Red For Women campaign was starting A more contemporaneous study may reveal a dwindling gap between risk factor presence and perceived risk of disease
  • 16. Collaborating Sites Group Health Cooperative: Jennifer McClure, PhD Seattle Julie Richards, Paula Sandler Roy Pardee HealthPartners: Cheri Rolnick, PhD Minneapolis Mary Kelley, MPH, Ann Hanson HFHS/HAP: Christine Cole Johnson, PhD, Gwen Alexander, PhD Detroit George Divine, PhD, Nancy Oje-Tebbe Sarah Claud, MPH, Heidi Kromrei,MA Rick Krajenta, Noel Maddy KP Colorado: Deb Ritzwoller, PhD, Anna Sukhanova Denver Melanie Stopponi, MPA, Nikki Carroll KP Georgia: Dennis Tolsma, MPH Atlalnta Jody Calvi, MPH U Michigan Center for Health Communications*: Vic Strecher, PhD Ed Saunders, Carola Carlier Janine Konkel, Mike Nowak Consultants: Mick Couper (UM Inst Soc Research) Marci Campbell, PhD, UNC Ken Resnicow, PhD, U Michigan Jerianne Heimendinger, PhD, RD Fran Thompson, PhD, RD Tom Hurley, PhD *Plus project team members, pilot testers and UM HMRL staff

Editor's Notes

  1. In a 2004 survey only 31% of women cited hyperlipidemia as a cause of CVD